Analyst Ratings for Rigel Pharmaceuticals (RIGL)
RIGL Rating Summary
RIGL Price Target Summary
- Highest: $85.00 (H.C. Wainwright)
- Lowest: $42.00 (Jefferies)
- Average: $61.25
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$61.25 (+28.9%)
* Over Last 12-Mos
Rating Score: 3.8 / 10
Percentile Rank: 36%
Avg. $ Target:
$61.25 (+28.9%)
* Over Last 12-Mos
Rating Score: 3.8 / 10
Percentile Rank: 36%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/5/2025 | Jefferies | Eun Yang | Upgrade | Buy (Hold) |
42.00 (23.00) |
28.38 (47.50) |
67.37% | Details |
| 4/3/2023 | Piper Sandler » Updated 8/17/2026 |
Allison Bratzel | New Coverage | Neutral (N/A) |
49.00 (40.00) |
1.34 (47.50) |
3444.78% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
